Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.
about
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomaImmunomic analysis of human sarcomaA gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytesDegeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humansAntigen processing in vivo and the elicitation of primary CTL responsesThe immunogenicity of a new human minor histocompatibility antigen results from differential antigen processingHuman tumor antigens recognized by T lymphocytesSynthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTLThe PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.Progress and controversies in developing cancer vaccines.Safety of targeting tumor endothelial cell antigensSecondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseIdentification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100.Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines.Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyMelanoma Peptide Vaccines.Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?Evaluation of the sentinel immunized node for immune monitoring of cancer vaccinesIdentification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsThe contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Identification by mass spectrometry of CD8(+)-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene productThe immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene productTumor antigens and tumor vaccines: peptides as immunogens.Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cellsContribution of mass spectrometry to contemporary immunology.Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning.Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model.Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays.Mass spectral data for 64 eluted peptides and structural modeling define peptide binding preferences for class I alleles in two chicken MHC-B haplotypes associated with opposite responses to Marek's diseaseRapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.From large analogical instruments to small digital black boxes: 40 years of progress in mass spectrometry and its role in proteomics. Part II 1985-2000.Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression
P2860
Q24307739-35CEFD55-958D-48D5-BA57-3DFFD794C8E9Q24554211-98B0B4B9-2486-4020-9D89-87012BC21ED5Q24647420-D472D641-D9D2-44DD-A535-A972CF87CC8CQ24673373-95786204-2759-4044-95C7-84E3B15468DEQ24675502-28A1E810-2DF4-4B99-8F62-E5571C81B48CQ24675797-3C8F46BF-5EC5-49B3-A8B1-CC2711942E26Q24678508-8C37CF18-B34E-42F2-8292-D51E77F085FDQ24684276-8714BD7A-299A-44C1-830D-A39200C3B99CQ24685666-AA524DED-F41B-43BA-9218-FFDCFE972473Q24810256-A21D3E3E-A903-4400-9D4C-C6CC00C3F721Q26748863-283E3E0E-D29A-45D7-B26F-9B8C372B2430Q27653882-FE7E4CC8-EA7C-4FD6-88AE-1DCEA508CA50Q28238379-EECFB9CA-3E25-4388-BAD4-E71C7CCC8CD7Q30252929-6CA33CC9-9CE0-4195-A477-D1A8709DF477Q30304153-E09D8433-ED10-45C1-9088-0093C1E98268Q30304290-736D4BAE-3D97-4C66-A751-91391C169083Q30305530-FB292825-7F20-4755-8E77-AD3520BAC944Q30305778-A8A0FE31-D318-4298-991F-522419946932Q30371547-6DAB6742-87C3-4AA3-B598-F3FF9E03DE9AQ30411499-02DCE2DC-36D0-44CC-98B1-A7C4CFE68A94Q30425111-46A4CB2E-C2EE-49BD-9F2E-695310F38A80Q30433911-359245DD-9EFB-4998-BF40-F80E09CA9FDBQ30436422-CFF545B1-D2A3-4B18-9EEE-122DC1C663E0Q30442808-3CA6B2ED-B9C7-41FC-96E1-6DAB4F9BED8CQ30442838-74B20F8E-E300-4E07-98EA-827261CE1C65Q30442847-F2D6E2E1-64DA-4712-A783-FB272807EE11Q30444065-1FF04B43-B4EB-4013-A58C-54F4C376D632Q30453239-DC1894D2-26CD-4517-A38E-00C4F0CF4F2FQ30453892-785DF062-7AA7-473B-9B8B-8B6B28EA8E0DQ30469630-3AEFA247-ACD4-4B11-AC49-94EFD564625CQ30621114-8DC90572-EE4A-4C64-A49E-DDB7AB5CEF63Q30697033-4486D8AA-0070-437A-82D8-7BA6E0F1302CQ30814677-1DE880F8-83A4-47FB-B362-52B7745063ECQ30831500-9D13DE9C-89A6-45EA-9E36-4A24E42019D7Q31045955-F7ED2513-963B-460D-8AD9-CB5341AFBCADQ31048160-BB83E5CA-26E3-4597-81C3-8C97A20F4D15Q31162016-190898A1-FF4C-4C79-8979-435AAB99A52DQ33222048-EB853F7C-02EE-4705-B7D7-4A4C49BE4304Q33487893-7C0EF8A8-372C-468E-B626-9FE44A6F4CDAQ33822591-A6F22184-9C82-4B87-89DA-FEC93295FCD8
P2860
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Identification of a peptide re ...... human cytotoxic T cell lines.
@ast
Identification of a peptide re ...... human cytotoxic T cell lines.
@en
type
label
Identification of a peptide re ...... human cytotoxic T cell lines.
@ast
Identification of a peptide re ...... human cytotoxic T cell lines.
@en
prefLabel
Identification of a peptide re ...... human cytotoxic T cell lines.
@ast
Identification of a peptide re ...... human cytotoxic T cell lines.
@en
P2093
P356
P1433
P1476
Identification of a peptide re ...... c human cytotoxic T cell lines
@en
P2093
C L Slingluff
J Shabanowitz
R A Henderson
T L Darrow
P304
P356
10.1126/SCIENCE.7513441
P407
P577
1994-04-01T00:00:00Z